These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11204170)

  • 1. Pathogenesis I: interactions of host cells and fungi.
    Clemons KV; Calich VL; Burger E; Filler SG; Grazziutti M; Murphy J; Roilides E; Campa A; Dias MR; Edwards JE; Fu Y; Fernandes-Bordignon G; Ibrahim A; Katsifa H; Lamaignere CG; Meloni-Bruneri LH; Rex J; Savary CA; Xidieh C
    Med Mycol; 2000; 38 Suppl 1():99-111. PubMed ID: 11204170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fungal invasion of normally non-phagocytic host cells.
    Filler SG; Sheppard DC
    PLoS Pathog; 2006 Dec; 2(12):e129. PubMed ID: 17196036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative ocular pathogenicity of Cryptococcus neoformans, Candida glabrata, and Aspergillus fumigatus in the rabbit.
    Fujita NK; Henderson DK; Hockey LJ; Guze LB; Edwards JE
    Invest Ophthalmol Vis Sci; 1982 Mar; 22(3):410-4. PubMed ID: 7037676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody-mediated protective immunity in fungal infections.
    Magliani W; Conti S; Arseni S; Salati A; Ravanetti L; Maffei DL; Giovati L; Polonelli L
    New Microbiol; 2005 Oct; 28(4):299-309. PubMed ID: 16386014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fungi pathogenic to humans: molecular bases of virulence of Candida albicans, Cryptococcus neoformans and Aspergillus fumigatus.
    Karkowska-Kuleta J; Rapala-Kozik M; Kozik A
    Acta Biochim Pol; 2009; 56(2):211-24. PubMed ID: 19543556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fungal morphogenesis and virulence.
    San-Blas G; Travassos LR; Fries BC; Goldman DL; Casadevall A; Carmona AK; Barros TF; Puccia R; Hostetter MK; Shanks SG; Copping VM; Knox Y; Gow NA
    Med Mycol; 2000; 38 Suppl 1():79-86. PubMed ID: 11204167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human fungal pathogens: Why should we learn?
    Kim JY
    J Microbiol; 2016 Mar; 54(3):145-8. PubMed ID: 26920875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of dendritic cells in the innate recognition of pathogenic fungi (A. fumigatus, C. neoformans and C. albicans).
    Ramirez-Ortiz ZG; Means TK
    Virulence; 2012 Nov; 3(7):635-46. PubMed ID: 23076328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of immunity in fungal infections.
    Chute HL
    Am J Vet Res; 1975 Apr; 36(4 Pt 2):601-2. PubMed ID: 1092228
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of current genome projects on the study of pathogenic and allergenic fungi.
    Breitenbach M; Crameri R; Lehrer SB
    Chem Immunol; 2002; 81():5-9. PubMed ID: 12102005
    [No Abstract]   [Full Text] [Related]  

  • 11. Overview of selected virulence attributes in Aspergillus fumigatus, Candida albicans, Cryptococcus neoformans, Trichophyton rubrum, and Exophiala dermatitidis.
    Boral H; Metin B; Döğen A; Seyedmousavi S; Ilkit M
    Fungal Genet Biol; 2018 Feb; 111():92-107. PubMed ID: 29102684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendritic cells and fungi.
    Buentke E; Scheynius A
    APMIS; 2003; 111(7-8):789-96. PubMed ID: 12974780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell wall proteome of pathogenic fungi.
    Karkowska-Kuleta J; Kozik A
    Acta Biochim Pol; 2015; 62(3):339-51. PubMed ID: 26192771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induced humoral immunity and vaccination against major human fungal pathogens.
    Casadevall A; Feldmesser M; Pirofski LA
    Curr Opin Microbiol; 2002 Aug; 5(4):386-91. PubMed ID: 12160857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune response to fungal infections.
    Blanco JL; Garcia ME
    Vet Immunol Immunopathol; 2008 Sep; 125(1-2):47-70. PubMed ID: 18565595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventative and therapeutic vaccines for fungal infections: from concept to implementation.
    Deepe GS
    Expert Rev Vaccines; 2004 Dec; 3(6):701-9. PubMed ID: 15606355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cells from X-linked hyper-IgM patients present impaired responses to Candida albicans and Paracoccidioides brasiliensis.
    Cabral-Marques O; Arslanian C; Ramos RN; Morato M; Schimke L; Soeiro Pereira PV; Jancar S; Ferreira JF; Weber CW; Kuntze G; Rosario-Filho NA; Costa Carvalho BT; Bergami-Santos PC; Hackett MJ; Ochs HD; Torgerson TR; Barbuto JA; Condino-Neto A
    J Allergy Clin Immunol; 2012 Mar; 129(3):778-86. PubMed ID: 22154528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plant production of anti-β-glucan antibodies for immunotherapy of fungal infections in humans.
    Capodicasa C; Chiani P; Bromuro C; De Bernardis F; Catellani M; Palma AS; Liu Y; Feizi T; Cassone A; Benvenuto E; Torosantucci A
    Plant Biotechnol J; 2011 Sep; 9(7):776-87. PubMed ID: 21265996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relative susceptibility of New Zealand black and CBA mice to infection with opportunistic fungal pathogens.
    Corbel MJ; Eades SM
    Sabouraudia; 1976 Mar; 14(1):17-32. PubMed ID: 772839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of inflammatory cytokines in a mouse model of keratomycosis].
    Yin HM; Zhong WX; Xie LX
    Zhonghua Yan Ke Za Zhi; 2010 Sep; 46(9):821-8. PubMed ID: 21092562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.